Drug Eluting Stents Vs. Bare Metals Stents Win Again
A new study funded by the Massachusetts Department of Public Health is showing further evidence to support the use of drug eluting stents over bare metal stents in heart attack patients. This study measured stent use specifically in diabetic patients. Drug-eluting stents showed improved outcomes as compared with bare metal stents in diabetics, and no excess adverse events were found with drug-eluting stents in diabetic patients. This data was reported by researchers at the American Heart Association’s Scientific Sessions 2008 in New Orleans. Some of the raw numbers appear marginal, but others are very impressive.
Drug-eluting stents reduced the risk of revascularization, heart attack and death in diabetics as compared with bare-metal stents in the largest observational comparison. The results were presented as a late-breaking clinical trial and is simultaneously published in circulation in the Journal of the American Heart Association.
Read more